Literature DB >> 30658448

Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.

Dar-Shong Lin1,2, Yu-Wen Huang3, Che-Sheng Ho4, Pi-Lien Hung5, Mei-Hsin Hsu6, Tuan-Jen Wang7, Tsu-Yen Wu8, Tsung-Han Lee9, Zo-Darr Huang10, Po-Chun Chang11, Ming-Fu Chiang12,13,14.   

Abstract

Dysfunction of mitochondria causes defects in oxidative phosphorylation system (OXPHOS) and increased production of reactive oxygen species (ROS) triggering the activation of the cell death pathway that underlies the pathogenesis of aging and various diseases. The process of autophagy to degrade damaged cytoplasmic components as well as dysfunctional mitochondria is essential for ensuring cell survival. We analyzed the role of autophagy inpatient-specific induced pluripotent stem (iPS) cells generated from fibroblasts of patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) with well-characterized mitochondrial DNA mutations and distinct OXPHOS defects. MELAS iPS cells recapitulated the pathogenesis of MELAS syndrome, and showed an increase of autophagy in comparison with its isogenic normal counterpart, whereas mitophagy is very scarce at the basal condition. Our results indicated that the existence of pathogenic mtDNA alone in mitochondrial disease was not sufficient to elicit the degradation of dysfunctional mitochondria. Nonetheless, oxidative insults induced bulk macroautophagy with the accumulation of autophagosomes and autolysosomes upon marked elevation of ROS, overload of intracellular calcium, and robust depolarization of mitochondrial membrane potential, while mitochondria respiratory function was impaired and widespread mitophagy compromised cell viability. Collectively, our studies provide insights into the dysfunction of autophagy and activation of mitophagy contributing to the pathological mechanism of mitochondrial disease.

Entities:  

Keywords:  MELAS; autophagy; iPS cells; mitochondrial diseases; mitophagy

Mesh:

Substances:

Year:  2019        PMID: 30658448      PMCID: PMC6356288          DOI: 10.3390/cells8010065

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


1. Introduction

Mitochondria are double-membrane-bound organelles with two mitochondrial compartments including the intermembrane space and the matrix. Mitochondria have a pivotal role in cell energy homeostasis which is of relevance to cellular physiology. The electron transport system and the adenosine triphosphate (ATP) sythase complex located on the inner mitochondrial membrane and enzymes in the matrix play a vital role in the proceeding of ATP production via the citric acid cycle, fatty acid oxidation and oxidative phosphorylation system (OXPHOS) [1]. Mitochondria DNA (mtDNA), located in the matrix, contains 37 genes encoding 13 proteins, 22 tRNAs, and two rRNAs [2]. The 13 mitochondrial genes encode 13 polypeptide subunits of the respiratory chain complexes of the oxidative phosphorylation system for cellular energy production, while the remaining 79 structural OXPHOS subunits are encoded by the nuclear genome [3]. Mutations of mtDNA result in OXPHOS defects which are characterized by a broad spectrum of clinical manifestations and multi-system involvement [4,5,6]. Of note, more than 50% of mtDNA mutations are located in 22 tRNA genes [7]. Whereas the A3243G mutation in the mitochondrial tRNA gene (MT-TL1) is one of the most common mtDNA mutations and can give rise to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), as well as maternally inherited diabetes and deafness [8,9]. High levels of A3243G mutation cause severe assembly defects of respiratory chain complexes I and IV leading to an impaired biogenesis, which is characterized with an increase in glycolytic flux, lactate, and reactive oxygen species (ROS) production, as well as a decrease in mitochondrial membrane potential and ATP synthesis [10,11,12]. Furthermore, the failure to switch substrate utilization from glucose oxidation to fatty acid oxidation in response to energy deficiency is mediated by 5′-adenosine monophosphate-activated protein kinase (AMPK) and may contribute to the development of the clinical phenotype [12]. Under normal conditions, cellular ROS can be scavenged by the antioxidant system to re-establish or maintain redox homeostasis. Nonetheless, cell damage occurs upon the failure of the cell’s antioxidant system, either exceeding its capacity or being less active, to purge the accumulation of ROS. The prevalence or accumulation of damaged organelles and aggregated protein within the cells can trigger the activation of cell death pathway, which has a deleterious impact upon tissues, organisms, and biological systems, and leads to the development of aging and various diseases. To maintain the cellular homeostasis and promote cell survival, the compromised cellular components are degraded by the process of autophagy into basic molecules for recycling in biosynthetic or catabolic processes [13]. Dysregulation or impairment of autophagy has been implicated in aging, infection, cancer, and degenerative diseases. To this date, studies of autophagy upon mitochondrial dysfunction induced by mtDNA A3243G mutation were limited to fibroblasts and cybrids; these studies showed controversial results and warrant more studies to unveil the mechanism [14,15,16]. Recently, the use of patient-specific induced pluripotent stem (iPS) cells enable to model of a unique human disease and contributed to a better understanding of its pathogenesis, to the discovery of new drugs, and to the development of novel therapy. In the present study, MELAS iPS cells harboring high levels of the mitochondrial A3243G mutation showed elevated levels of autophagy and scarcity of mitophagy in comparison with its normal counterpart harboring an isogenic background. Oxidative insults induced a marked increase of bulk macroautophagy, autophagic flux dysfunction, and broad activation of mitophagy, and led to compromised cell viability in the MELAS iPS cells.

2. Material and Methods

2.1. Generation of iPS Cell and Culture

In compliance with the Declaration of Helsinki of the World Medical Association, informed consent form was approved by the Institutional Review Board of Mackay Memorial Hospital and was obtained from the patient before any investigation of this study. Primary skin fibroblasts derived from patient with MELAS syndrome harboring mtDNA A3243G mutation were cultured in standard Dulbecco’s modified Eagle medium (DMEM; Invitrogen, Carlsbad, CA, USA), supplemented with 10% (v/v) fetal bovine serum (FBS; Life Technologies, Grand Island, NY, USA) and 1% penicillin G/streptomycin sulfate, in a humidified atmosphere of 5% (v/v) CO2 at 37 °C. Reprogramming of fibroblasts was carried out with a modified, non-transmissible form of Sendai virus according to the manufacturer’s protocol (CytoTune-iPS Reprogramming Kit, Thermo Fisher Scientific, Waltham, MA, USA). After transduction, undifferentiated iPS colonies were isolated manually and propagated in Essential 8™ Medium (Thermo Fishers Scientific) on vitronectin-coated culture dishes. When indicated, the iPS cells were plated at a density of 400,000 cells per well of a six-well cell culture plate overnight. The next day, iPS cells were treated with or without 2 μM Carbonyl cyanide m-chlorophenylhydrazone (CCCP) for 4 h in the absence or presence of Bafilomycin (BAF).

2.2. Immunohistochemistry

Cultured cells were fixed with 4% paraformaldehyde in Phosphate-buffered saline (PBS) for 20 min at room temperature, rinsed three times with PBS, then permeabilized with 0.2% Triton X-100 in PBS for 10 min. Cells were blocked with 10% goat serum (Sigma, St Louis, MO, USA) for 1 h at room temperature, incubated with primary antibodies for 1 h at room temperature, rinsed 3 times with PBS, then incubated with secondary antibodies (1:500, Molecular Probes, Invitrogen) for 1 h at room temperature. The cells were washed three times with PBS, counterstained with 4′,6-diamidino-2-phenylindole (DAPI), and visualized under fluorescence microscope. Primary antibodies were: Lin-28 Homolog A (LIN28, 1:100, GeneTex, Irvine, CA, USA), Octamer-binding transcription factor 4 (OCT4, 1:100, Genetex), stage-specific embryonic antigen (SSEA4, 1:100, Thermo Fisher Scientific) and carbonhydrate TRA-1-60 epitope (1:100, Thermo Fisher Scientific).

2.3. Live Cell Oxygen Consumption

Bioenergetic profiles were determined using the XF24 extracellular flux analyzer (Seahorse Biosciences, Santa Clara, CA, USA). iPS cells were seeded at a density of 40,000 cells per well of a XF24 cell culture microplate and maintained in Essential 8™ Medium overnight in a humidified atmosphere of 5% (v/v) CO2 at 37 °C. Before assay, iPS cells were equilibrated in unbuffered DMEM medium (Life Technologies) supplemented with 25 mM glucose, 1 mM sodium pyruvate, 2 mM L-Glutamine and transferred to a non-CO2 incubator for 1 h before measurement. Oxygen consumption rate (OCR) was measured with sequential injections of different concentration of CCCP and each 0.4 μM of rotenone/antimycin A. OCR was increased immediately after the addition of CCCP, which enabled the measurement of maximal mitochondrial respiration, and was completely abolished after the inhibition of OXPHOS by injection of rotenone/antimycin A. Each plotted value of real-time assessment of mitochondrial respiration was represented as percentage of basal OCR. Results were presented as mean ± SEM.

2.4. Western Blot Analysis

The cells were harvested and lysed with Radio-Immune Precipitation Assay (RIPA) lysis buffer. The supernatant was collected after centrifugation of the cell lysate and the protein was measured using the bicinchoninic acid (BCA) protein assay (Thermo Fisher Scientific). An aliquot of 20 μg of whole cell extracts was separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) using 10% or 12% polyacrylamide gels. After electrophoresis, proteins were transferred to a piece of Polyvinylidene difluoride membrane (PVDF), which was immunoblotted for Microtubule Associated Protein Light Chain 3 (LC3, 1:1000, Sigma), Complex I subunit Ubiquinone Oxidoreductase Subunit B8 (NDUFB8), Complex II subunit Succinate Dehydrogenase Complex Iron Sulfur Subunit B (SDHB), Complex III subunit Ubiquinol-Cytochrome C Reductase Core Protein 2 (UQCRC2), Complex IV subunit Mitochondrially Encoded Cytochrome C Oxidase II (MTCO2), Complex V subunit ATP Synthase F1 Subunit Alpha (ATP5A), porin (1:1000; Abcam, Cambridge, MA, USA), Myelocytomatosis oncogene cellular homolog (c-Myc), Kruppel Like Factor 4 (Klf4), Lin-28 Homolog A (Lin28A), Octamer-binding transcription factor 4 (Oct4), and SRY-Box 2 (Sox2) (1:1000, Genetex) for 2 h at room temperature. The PVDF membrane was then washed, probed with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature, washed again, and then visualized by enhanced chemiluminescence (GE, Healthcare Life Sciences, Chicago, IL, USA).

2.5. Detection of Autophagosomes, Autolysosomes and Mitochondria

In brief, after treatment of the iPS cells with or without 2 μM CCCP for 4 h, the cells were stained with CYTO-ID Green detection reagent (Enzo Life Science, Farmingdale, NY, USA), LysoTrakcer Red (Thermo Fisher Scientific), MitoTracker Green (Thermo Fisher Scientific), respectively, and counterstained with Hoechst 33342, according to the manufacturer’s protocol. Images were obtained using a fluorescent microscope. To quantize the levels of autophagosomes, the iPS cells, in the presence or absence of CCCP, were trypsinized, centrifuged, washed, and resuspended in CYTO-ID assay buffer. After staining them with CYTO-ID Green detection reagent, the iPS cells were centrifuged, washed, resuspended in assay buffer, and analyzed on a flow cytometer.

2.6. Reactive Oxygen Species (ROS) Detection Using a Fluorescent Agent MitoSox

Superoxide anion levels were measured using the fluorescent dye MitoSox Red (Thermo Fisher Scientific). The iPS cells were treated with MitoSox Red (5 μM) for 10 min at 37 °C in the dark, washed, and counterstained with DAPI for 5min. Images were obtained using a fluorescent microscope. To qualify the levels of reactive oxygen species, the iPS cells were seeded on a 96-well plate and treated with or without 2 μM CCCP for 4 h, then incubated with MitoSox Red (5 μM) for 10 min at 37 °C in the dark, and washed with 0.1% FBS in HHBS. The fluorescent intensity was read with a microplate reader (Infinite M200PRO, TECAN, Mannedorf, Switzerland). All measurements, normalized for number of cells, were presented as mean ± SEM. Cell numbers were quantified by the CyQUANT cell proliferation assay kit (Molecular Probes, Invitrogen).

2.7. Measurement of Mitochondrial Membrane Potential

The iPS cells were seeded on a 96-well plate and treated with/without 2 μM CCCP for 1 h, then incubated with tetramethylrhodamine ethyl ester (TMRE, 50 nm; Thermo Fisher Scientific) for 20 min at 37 °C in the dark, and washed with 0.2% BSA in PBS. The fluorescent intensity was read with a microplate reader, and the images were obtained using a fluorescent microscope. All measurements, normalized for number of cells, were presented as mean ± SEM. Cell numbers were quantified by the CyQUANT® cell proliferation assay kit.

2.8. Detection of Intracellular Calcium Mobilization

The iPS cells were seeded on a 96-well plate and treated with/without 2 μM CCCP for 4 h, incubated with Fluo-8 calcium assay kit (AAT Bioquest, Sunnyvale, CA, USA) for 1 h at 37 °C, 5% CO2 in incubator, and washed with Hank’s Buffer with HEPES (HHBS) according to the manufacturer’s protocol. The fluorescent intensity was read with a microplate reader. All measurements, normalized for number of cells, were presented as mean ± SEM. Cell numbers were quantified by the CyQUANT cell proliferation assay kit.

2.9. Measurement of Intracellular ATP Content

The intracellular ATP content was measured by the ATPliteTM Luminescence Assay system (PerkinElmer, Boston, MA, USA) according to the instruction of manufacturer. Briefly, the iPS cells were seeded on a 96-well plate and treated with/without 2 μM CCCP for 4 h, washed with PBS, mixed with mammalian cell lysis solution, shacked for 5 min at 800× g, mixed with substrate solution, and shacked for 5 min at 800× g to release the intracellular ATP. The 96-well culture plate was dark-adapted for 10 min. Luminescence intensity from each well was measured using an Infinite 200 pro plate reader (TECAN). The intracellular ATP content was normalized by the cell number. Cell numbers were quantified by the CyQUANT cell proliferation assay kit.

2.10. Cell Viability Assay

The iPS cells were seeded on a 96-well plate and treated with or without 2 μM CCCP for 4 h in a humidified atmosphere of 5% (v/v) CO2 at 37 °C. Cell numbers were quantified by the CyQUANT cell proliferation assay kit. Cells were incubated with CyQUANT dye at 37 °C for 30 min and fluorescence intensity was measured on a plate reader at OD = 530 nm.

2.11. Statistical Analysis

All data were obtained from at least three independent experiments and results were expressed as the mean ± SEM, unless stated otherwise. An ANOVA test was used for multiple comparisons. When p-values were less than 0.05, they were considered significant.

3. Results

3.1. Identifying Cell Surface Markers and Respiratory Complexes for the iPS Cells

We reprogrammed fibroblasts from a seven year-old boy with MELAS syndrome harboring 95% mtDNA A3243G mutation to iPS cells using retroviral vectors expressing Oct4, Klf4, Sox2, and c-Myc [12,17]. Mutation segregation occurred in individual iPS cell lines generated from A3243G fibroblasts. Both isogenic iPS cell lines carried 85% heteroplasmy (MELAS iPS) and undetectable A3243G mutation (control iPS), respectively, and showed expression of pluripotent markers (Figure 1A,B). It has been noted that cells with a proportion of pathogenic mitochondrial tRNA mutation lower than 85% to 90% maintains its normal physiological function and phenotype [18]. The MELAS iPS cells demonstrated deficiency of respiratory complexes I and IV in line with its parental fibroblasts (Figure 1C,D) [12].
Figure 1

Induced pluripotent stem (iPS) cells derived from fibroblasts of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome patient. (A) Immunocytochemical analyses showed positive expression of pluripotency markers Lin28, Oct4, SSEA4 and Tra-1-60 on both control and MELAS iPS cells. (B) Western blots showing the expression of c-Myc, Klf4, Lin28A, Oct4, Sox2 in iPS cells. (C) Western blots showing the expression of respiratory complexes in fibroblasts and iPS cells, respectively. (D) Quantification of respiratory chain complex proteins in iPS cells represented as fold of normal. All measurements are expressed as mean values ± SEM, n = 3–5. Comparisons with the control cells were performed by the ANOVA-test. ** p < 0.01, # p < 0.001, versus control. Scale bar: 20 μm.

3.2. Enhanced Flux of Autophagy

Autophagy is considered to be a dynamic process comprising the formation of autophagosomes, autolysosomes, and the degradation of autophagic substrates. Evaluation of the amount of LC3-II is the most widely used autophagosome marker to correlate the flux of autophagy with the number of autophagosomes. CCCP is a protonophore which uncouples oxidative phosphorylation, induces ROS and depolarizes mitochondrial membrane potential, thus, triggering mitophagy and bulk autophagy [19]. Researchers have typically challenged cells with CCCP to initiate the autophagy for assessing the oxidative stress induced autophagic flux and mitophagy. Bafilomycin is commonly used to inhibit autophagy by targeting lysosomes. To determine the level of autophagy in MELAS cells, the classical autophagy markers LC3-I and LC3-II were analyzed following treatment with or without CCCP in the absence or presence of bafilomycin. Western blot analysis revealed a significant increase of LC3II/LC3I ratio in MELAS iPS cells compared to control iPS cells at basal level (2.65 versus 1.0), treatment with either CCCP (15.90 versus 8.33) or bafilomycin (11.32 versus 4.90) alone, and a combination of CCCP and bafilomycin (17.10 versus 8.40), respectively (Figure 2A,B). The treatment of bafilomycin in control and MELAS iPS cells led to a significant increase in the LC3-II/LC3-I ratio, suggesting that the lysosomal flux is normal in both iPS cell lines. Treatment with CCCP in MELAS iPS cells led to a significantly higher surge of LC3-II/LC3-I ratio in comparison with control iPS cells. These results indicated an enhanced autophagy flux in MELAS iPS cells at basal condition and upon oxidative stress.
Figure 2

Increase of autophagic flux in MELAS iPS cells. (A) Western blots of LC3 expression of iPS cells in the presence or absence of bafilomycin (BAF) and Carbonyl cyanide m-chlorophenylhydrazone (CCCP), respectively, for the study of autophagic flux. (B) Quantification of LC3 levels normalized for β-actin. (C) Microscopy fluorescence images showing autophagosomes stained by Cyto-ID green dye. Small arrow indicates small puncta. Arrow head indicates large puncta. Large arrow indicates enlarged puncta. (D) Representative flow cytometry histogram and quantification of Cyto-ID green fluorescence levels normalized for number of cells. (E) Microscopy fluorescence images showing autolysosomes by colocalization of Cyto-ID green dye and LysoTracker Red. Small arrow indicates small puncta. Arrow head indicates large puncta. Large arrow indicates enlarged puncta co-localized with Cyto-ID green and LysoTracker Red. All measurements are expressed as mean values ± SEM, n = 3–5. * p < 0.05, ** p < 0.01, # p < 0.001, versus control. RFU: relative fluorescence unit. Scale bar: 20 μm.

3.3. Accumulation of Autophagosomes

When considering the ectopic localization of LC3-II on non-autophagosome structures, the expression levels of LC3-II at a specific time does not necessarily represent the overall autophagic activity [20,21]. Thus, to further validate the activity of autophagy flux, iPS cells were live stained with Cyto-ID Green fluorescent dye and autophagosomes are visualized under fluorescent microscopy (Figure 2C) [22]. Both control and MELAS iPS cells showed Cyto-ID stained fluorescent dots at basal condition and in the presence of CCCP. On the other hand, MELAS iPS cells showed more large punctate structures (autophagosomes) in comparison with the control iPS cells upon exposure to CCCP. Moreover, to quantify the levels of autophagosomes in live cells, the increase in Cyto-ID Green autophagy dye fluorescence signals was determined by flow cytometry [22]. Our results showed a significant increase of autophagosomes in MELAS iPS cells compared to that of control iPS cells at basal condition and in the presence of CCCP (Figure 2D). These observations correlated with the marked increase of LC3 expression assayed by western blotting in MELAS iPS cells (Figure 2A,B), indicating the increase of bulk macroautophagy and accumulation of autophagosome upon oxidative stress.

3.4. Accumulation of Autolysosomes

Autophagosomes fuse with lysosomes to form autolysosomes where autophagosomal contents are degraded by proteases within the lysosomes. Fusion between autophagosomes and lysosomes could be visualized by using Cyto-ID Green fluorescent dye and LysoTracker Red to stain autophagosomes and lysosomes, respectively. Under fluorescent microscopy, both iPS cells showed small puncta with positive LysoTracker Red fluorescence in the absence or presence of CCCP, and large puncta staining with LysoTracker Red upon exposure to CCCP (Figure 2E). While MELAS iPS cells demonstrated numerous small puncta and enlarged puncta with LysoTracker Red fluorescence in comparison with the control iPS cells. These findings suggested an increase of lysosomal flux in the MELAS iPS cells. Moreover, the colocalization of Cyto-ID Green fluorescence and LysoTracker Red fluorescence occurred concurrently forming enlarged puncta, and indicated the formation of autolysosome which accumulated more specifically in the MELAS iPS cells upon exposure to CCCP.

3.5. Remarked Increase of ROS

The effect of CCCP on mitochondrial ROS production in iPS cells was analyzed by using the fluorescent dye MitoSox Red, which is highly selective for the detection of superoxide in the mitochondria of live cells. Red fluorescence was exhibited when MitoSox Red reagent is readily oxidized by the superoxide in the mitochondria. Furthermore, the oxidation product exhibits a high fluorescence upon binding to nucleic acids. Incubation with CCCP led to a significant increase in MitoSox fluorescence in both iPS cell lines, whereas MELAS iPS cells showed strong intensity of MitoSox fluorescence in the cytoplasm compared to the control iPS cells (Figure 3A). There were also strong fluorescent spots in the nuclei of MELAS iPS cells, without colocalization with fluorescence of MitoTracker Green (data not shown), suggesting the production of superoxide in the nuclei. It has been reported that superoxide radical generated by nuclei as well as by other membranous structures results in DNA base modification and formation of nicks in DNA strands leading to deleterious biological consequences [23]. Furthermore, recent studies indicate that respiratory complex IV deficiency contributes to nuclear and mitochondrial DNA damage [24,25].
Figure 3

Increase of reactive oxygen species (ROS), intracellular calcium, and mitochondrial depolarization in MELAS iPS cells. (A) Representative microscopy fluorescence images showing levels of ROS by staining with MitoSox Red in iPS cells in the presence or absence of CCCP. (B) Quantification of ROS levels by analyzing the fluorescence intensity of MitoSox Red. (C) Representative microscopy fluorescence images showing levels of intracellular calcium by staining with calcium-sensitive fluorescent dye, fluo-8, in iPS cells in the presence or absence of CCCP. (D) Quantification of intracellular calcium levels by analyzing the fluorescence intensity of fluo-8. (E) Microscopy fluorescence images showing levels of mitochondrial depolarization by staining with tetramethylrhodamine ethyl ester (TMRE) in iPS cells in the presence or absence of CCCP. (F) Quantification of mitochondrial depolarization levels by analyzing the fluorescence intensity of TMRE. All measurements, normalized for number of cells, are expressed as mean values ± SEM, n = 3–5. ** p < 0.01, # p < 0.001, versus control. RFU: relative fluorescence unit. Scale bar: 20 μm.

Lastly, qualification of the intracellular levels of superoxides revealed a significant increase in both iPS cell lines after incubation with CCCP (Figure 3B). Of note, MELAS iPS cells showed a significantly elevated level of superoxide compared to the control iPS cells at basal condition and in the presence of CCCP, respectively. Additionally, the fold increase of superoxide from basal condition to the exposure to CCCP in MELAS iPS cells was higher than that of control iPS cells.

3.6. Overload of Cytoplasmic Calcium Flux

High levels of reactive oxygen and nitrogen species can compromise normal physiological pathways and induce cell death. Oxidative stress increases the calcium influx into the cytoplasm from the extracellular compartment and from the sarco/endoplasmic reticulum through a combination of effects on calcium pumps, exchangers, channels, and binding proteins [26,27]. A rising cytoplasmic concentration of calcium induces calcium influx into the mitochondria and nuclei and leads to down-regulation of mitochondrial metabolism, and subsequently, cell death. The presence of cytosolic calcium was defined and measured by staining with the calcium-sensitive fluorescent dye, fluo-8. Exposure to CCCP induced release of calcium into the cytoplasm in both control and MELAS iPS cells (Figure 3C).It should be noted that, although in the presence of CCCP bright tiny spots were highly abundant within the cytoplasmic region, MELAS iPS cells showed more fluorescent intensity and spots in the cytoplasm. Quantification of the intracellular calcium concentration demonstrated a significant increase of calcium concentration in both iPS cell lines after incubation with CCCP (Figure 3D). Intriguingly, MELAS iPS cells showed a significantly higher concentration of intracellular calcium than that of the control iPS cells at basal conditions and in the presence of CCCP. Additionally, the increase of intracellular calcium concentration between basal condition and with the exposure to CCCP in MELAS iPS cells was also higher than that of the control iPS cells. These results suggested an enhanced increase of calcium influx into the cytoplasm of MELAS iPS cells in response to oxidative stress.

3.7. Robust Depolarization of Mitochondrial Membrane Potential

The increase of ROS and calcium overload in the cytoplasm triggers the opening of the mitochondrial permeability transition pores and leads to dissipation of mitochondrial membrane potential (ΔΨm), reduction of mitochondrial ATP production, and induction of apoptosis and cell death [28,29]. To determine the level of mitochondrial membrane potential, iPS cells were stained with a fluorescent dye, tetramethylrhodamine ethyl ester (TMRE), which redistributes across the cell membrane, accumulates in mitochondria in a voltage-dependent manner, and does not interfere with the cell proliferation and viability [21]. While mitochondrial ΔΨm collapses in apoptotic cells, the even redistribution of TMRE in the cytosols produced a lower level of fluorescence. Under fluorescent microscopy, we observed a less intense fluorescence of TMRE in MELAS iPS cells compared to that in the control iPS cells at basal conditions. This suggested a loss of mitochondrial membrane potential resulting from OXPHOS defects in MELAS iPS cells (Figure 3E). After incubation with CCCP, TMRE fluorescence declined in both iPS cell lines, while MELAS iPS cells demonstrated a broad loss of fluorescence in comparison with that of control iPS cells. Quantitative measurement of mitochondrial membrane potential by the intensity of emitted TMRE fluorescence further provided a better functional assessment of the dynamic changes to cell activity. We found that ΔΨm of MELAS iPS cells was 58%of the control iPS at the basal condition and declined to 14% after treatment with CCCP (Figure 3F), whereas ΔΨm of the control iPS cells declined to 21.9% of its basal condition in the presence of CCCP. These findings were consistent with the observations under fluorescent microscopy. Taken together, the dynamic changes of ΔΨm were inversely related to the elevation of ROS and intracellular calcium levels.

3.8. Activation of Mitophagy Upon Oxidative Insults

To determine whether increased degradation of mitochondria occurred in the MELAS iPS cells during the phase of enhanced autophagy, iPS cells were double stained with LysoTracker Red and MitoTracker Green fluorescent dyes to concurrently label lysosome and mitochondria, respectively. The observation of small fragmented mitochondria was more evident in MELAS iPS cells, whereas a tubular mitochondrial network was clearly distinct in control iPS cells (Figure 4). Moreover, with the LysoTracker Red fluorescence and in comparison with the control iPS cells, the small fragmented mitochondria engulfed within enlarged puncta (autolysosome) broadly visualized in the MELAS iPS cells on exposure to CCCP suggested an enhanced mitophagy degrading damaged mitochondria within autolysosomes. Conversely, mitophagy was very scarce in MELAS iPS and control iPS cells at the basal condition. This observation was consistent with previous findings, whereby selective elimination of mitochondria containing pathogenic mtDNAs is spared in mitochondrial diseases under basal conditions [16].
Figure 4

Activation of mitophagy in MELAS iPS cells. Microscopy fluorescence images showing levels of mitophagy after double staining with MitoTracker Green and LysoTracker Red in iPS cells in the presence or absence of CCCP. Colocolization fluorescence of MitoTracker Green and LysoTracker Red are indicative of mitophagy. The lower row shows magnification of the boxed area in the panel. Arrow indicates tubular mitochondria. Arrow head indicates fragmented mitochondria. Scale bar: 20 μm.

3.9. Decrease of Cellular Bioenergetics

Real-time assessment of mitochondrial respiration in MELAS iPS cells and its isogenic counterpart (control iPS) was determined by titrating the concentration of protonophore CCCP inducing the maximal oxygen consumption that is subsequently inhibited by rotenone and antimycin A. OCR of MELAS iPS cells remained at a maximal plateau in the presence of 0.25 μM CCCP (Figure 5A), whereas, during the incubation of CCCP from 0.5 to 2 μM (Figure 5B–D), it achieved its maximal level immediately and declined rapidly. On the contrary, the immediate rise and gradual decline from maximal OCR were observed in the control iPS cells upon exposure to a high concentrations (1 μM and 1.5 μM) of CCCP (Figure 5C,D). Overall, the control iPS cells maintained uncoupled respiration at higher OCR, whereas MELAS iPS cells displayed significantly attenuated levels of OCR during the exposure to CCCP at different concentrations. These findings highlighted the impact of OXPHOS deficiency on the mitochondrial function and the declined capacity of mitochondrial respiration upon oxidative insults.
Figure 5

Decreased oxygen consumption rate, ATP production and cell viability. (A–D)Control cells were able to maintain uncoupled respiration at a higher oxygen consumption rate (OCR) in the presence of CCCP at different concentrations in comparison with MELAS iPS cells. (E) Intracellular content of ATP was determined in the presence or absence of CCCP. (F) MELAS iPS cells showed a significant decline in cell viability in the presence of CCCP in comparison with control iPS cells. All measurements are expressed as mean values ± SEM, n = 3–5. * p < 0.05, ** p < 0.01, # p < 0.001, versus control.

3.10. Deficiency of Intracellular ATP Content

The cellular ATP production of the MELAS iPS cells cultured in basal condition and in the presence of CCCP was determined. Levels of ATP production in the MELAS iPS cells was significantly lower than in the control iPS cells at basal condition (Figure 5E). While in the presence of CCCP, the levels of ATP production in MELAS iPS cells were also significantly lower than in the cells at basal condition, the mean level of ATP production in control iPS cells in the presence of CCCP as compared to basal condition was slightly decreased, though not significantly. These observations suggested the vulnerability of MELAS iPS cells to oxidative stress.

3.11. Decrease of Cell Viability

Excess ROS production has an impact on many cellular biomolecules, including membrane phospholipids, respiratory chain complexes, proteins, and mitochondrial DNA. Consequently, this may lead to cellular dysfunction, and ultimately, cell death. Cell viability upon exposure to CCCP-induced oxidative stress was determined in both control and MELAS iPS cells. Both iPS cells with the same amount were plated in basal culture media for 24 h, then, the cell viability in the presence of CCCP between each iPS cell lines was compared. Both iPS cells lines were vulnerable to CCCP-mediated oxidative stress as shown by the significant decline of cell viability in the presence of CCCP. It should be noted that the cell viability of MELAS iPS cells was consistently significantly lower than that of control iPS cells in the presence of CCCP.

4. Discussion

In this work, we demonstrated that aggravation of autophagy dysfunction and mitophagy by CCCP in MELAS iPS cells is contributing to decreased cellular viability in comparison with its normal counterpart. This phenomenon could be explained by the combination of an increased level of ROS, calcium leakage from the intracellular store [26,27], loss of mitochondrial membrane potential, and ultimately the deficiency of energy production. The iPS cells with high heteroplasmy of A3243G mutation showed a deficiency of respiratory complexes I and IV, impairment of respiratory function, attenuated ATP generation, and decreased cell proliferation. These results are all the expected characteristics of fibroblast harboring defects in the OXPHOS system [12]. Furthermore, it has been observed that severe assembly defects and enzyme activities of Complexes I and IV, impaired respiratory function, high level of ROS, low mitochondrial membrane potential, reliance on anaerobic glycolysis, and energy deficiency contribute to the underlying pathogenic mechanism of the MELAS syndrome [30,31]. In this study, we successfully provided iPS cells characterizing the pathogenesis of MELAS syndrome for disease modeling and pathomechanism identification. With the advantage of retainment of cytoplasmic genetic material during direct reprogramming and variation for mtDNA mutation heteroplasmy during cell passage, isogenic iPS cell clones with high mutant mtDNA burden and without mtDNA mutation could both be isolated simultaneously for observation of the impact of mtDNA heteroplasmy on pathomechanism of mitochondrial diseases [32,33]. In this study, we used isogenic iPS cells with and without high burden of A3243G mutation, and identified an elevated level of autophagy and accumulation of autophagic vesicles in MELAS iPS cells. Recent researches regarding the autophagy in MELAS syndrome have been limited to patient-derived fibroblasts and cybrid cell lines [14,15,16,34]. In the work of Sanchez-Alcazar’s et al., MELAS fibroblasts harboring mtDNA A3243G mutation with 4% to 73% heteroplasmy showed elevated levels of ROS, deficiencies of respiratory complexes I, II, III and IV, dysfunctional mitochondrial activity, impaired autophagic flux, and activation of mitophagy in comparison to normal control cells with different genetic backgrounds [14,15,34]. Of note, a progressive increase in mtDNA A3243G heteroplasmy correlates with the severity of phenotype. Individuals with a lower percentage of A3243G heteroplasmy can face mitochondrial diabetes and autism, and individuals with 90–100% A3243G heteroplasmy are most commonly affected with MELAS syndrome or perinatal lethality [35]. Thus, marked tissue-specific differences and variation of genetic background may modulate the pathogenic expression of the A3243G mutation and the prognosis of mitochondrial diseases [36,37]. To avoid the impact of the genetic background on signal transduction and epigenetic regulation, tumor-derived cytoplasmic hybrid (cybrid) cell lines have been used broadly in the study of mitochondrial diseases [16,35,38]. In a study by Schon’s group, there was no appreciable increase of autophagy in A3243G cybrid cells in the presence or absence of rapamycin compared to that in wild-type cybrid cells, while Sanchez-Alcazar’s group found a significant increase in the ratio of LC3-II to LC3-I in MELAS cybrid cells in comparison with the control cybrid cells [15,16]. Another study further demonstrated a difference in the bioenergetic profile and mitophagy between cybrids derived from adenocarcinoma and rhabdomyosarcoma harboring heteroplasmic A3243G mutation [39]. These findings highlighted the link between genetic background and cell-type dependent regulation of mitochondrial function, and revealed the impact of discrepant results from cell-specific cybrids on the approach for the study of mitochondrial diseases. In the present study, a higher than normal level of the autophagosomal marker LC3-II was detected in MELAS iPS cells indicating an increase of autophagic flux at the basal condition, while the ATP production was deficient. Previous studies have demonstrated that lower levels of ATP production due to OXPHOS defect in mitochondrial diseases is insufficient for the maintenance of normal cellular function and could trigger autophagy via activation of AMPK and inhibition of mammalian target of rapamycin complex 1 (mTORC1) [12,40,41,42]. Moreover, microscopic observations unveiled a marked increase of enlarged puncta of autophagosomes and autolysosomes in MELAS iPS cells treated with CCCP, suggesting an accumulation of autophagosomes and autolysosomes. Collectively, the enhanced autophagy and accumulation of autophagosomes and autolysosomes implied a disruption of the autophagic flux in MELAS iPS cells upon oxidative stress. These findings are consistent with previous studies reporting that impaired autophagic flux leads to the accumulation of autophagosomes and lysosomes in OXPHOS deficient fibroblasts harboring nuclear DNA mutations [43]. In addition, midbrain of a murine model with mtDNA deletion due to mutant Twinkle demonstrated impairment of mitochondrial respiratory function and increase of autophagy resulting to neurodegeneration, while an accumulation of autophagosomes was observed in the retinal ganglions of murine model of dominant optic atrophy with disrupted mitochondrial dynamics [44,45,46]. It has been indicated that excessive autophagosomes reduces the rate-limiting lysosomal activity and leads to a blockade of autophagy and the accumulation of autophagosomes, further causing a disruption to autophagy and induction of cell toxicity subsequently [47]. Our results also demonstrated a marked increase in ROS production, elevation of intracellular calcium, depolarization of mitochondrial membrane potential, and decreased cell viability in MELAS iPS cells following treatment of protonophore CCCP, and suggested that ROS contributes to cell toxicity. It has previously been observed that oxidative stress induces calcium influx from endoplasmic reticulum into the cytoplasm, nuclei, and mitochondria, and leads to disruption of the normal metabolism and signal transduction pathway [48]. Furthermore, mitochondrial calcium overload after a massive calcium flux causes opening of the mitochondrial permeability transition pores resulting in the mitochondrial membrane depolarization, mitochondrial dysfunctions, damages, and ultimately cell death [49,50,51]. Autophagy is induced by mitochondrial depolarization to eliminate the damaged or dysfunctional mitochondria, a specific process called mitophagy that attenuates apoptosis or necrosis [52,53]. Indeed, our results also observed an induction of mitophagy in MELAS iPS cells in the presence of CCCP, whereas mitophagy was scarce at the basal condition, even during a state of enhanced general autophagy. These observations were consistent with previous studies in that mitochondrial defects alone were not sufficient to initiate selective mitophagy in a mitochondrial disease [16]. Moreover, our results further implied that robust collapse of mitochondrial membrane potential and OXPHOS defect synergistically induce mitophagy to eliminate damaged mitochondria. Of note, the levels of Parkin were indistinguishable between control and MELAS iPS cells (unpublished data) in our results, in contrast to previous studies using immortalized cells indicated the initiation of extensive mitophagy upon the combination of macroautophagy and Parkin-mediated mitophagy pathway [16,54]. Our observations were consistent with other studies using neuron cells, which failed to demonstrate Parkin-mediated mitophagy upon enhanced mitochondrial depolarization even with excessive Parkin–mitochondrial localization [55]. Furthermore, another study using fibroblasts showed Parkin recruitment to mitochondria of control cells and OXPHOS defective cells with diminished mitochondrial membrane potential, respectively, without initiation of mitophagy [43]. Given our results and those previously reported, we speculate that additional mechanisms other than Parkin may regulate the initiation of mitophagy. Recently, several studies have identified novel regulators of mitophagy through Parkin-independent pathway for cellular homeostasis [56,57,58]. Thus, further studies analyzing the regulation of mitophagy-related signaling cascades in an iPS cell model of mtDNA mutation are needed to shade more light on the pathological mechanism of mitochondrial diseases. In conclusion, the iPS cellular model recapitulates the pathogenesis of MELAS syndrome and holds promises for the determination of a pathological mechanism as both the isogenic iPS cells with undetectable-mutation and the high heteroplasmy of mutant mtDNA could be established from parental cells. Of note, mitophagy was scarce in MELAS iPS cells at the basal condition during elevated autophagy; this explained the accumulation and heteroplasmy of pathogenic mtDNA in human patients under the same physiological conditions. Moreover, the combination of the mtDNA mutation and the oxidative insults elicit bulk macroautophagy with an accumulation of autophagosomes and autolysosomes, and leads to the promotion of cell toxicity, activation of mitophagy, and subsequently, the decrease of cell viability. Although there was a limitation of available samples in this patient-specific iPS cells, our results were performed comprehensively and completely in unveiling the role of autophagy in MELAS syndrome. They provided further insights into the autophagy dysfunction and contributed to a better understanding of the pathological mechanism of mitochondrial diseases.
  58 in total

1.  Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA.

Authors:  Adriana Malena; Boris Pantic; Doriana Borgia; Gianluca Sgarbi; Giancarlo Solaini; Ian J Holt; Antonella Spinazzola; Egle Perissinotto; Marco Sandri; Alessandra Baracca; Lodovica Vergani
Journal:  Autophagy       Date:  2016-09-14       Impact factor: 16.016

Review 2.  Cell Biology of the Mitochondrion.

Authors:  Alexander M van der Bliek; Margaret M Sedensky; Phil G Morgan
Journal:  Genetics       Date:  2017-11       Impact factor: 4.562

3.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

4.  Mitochondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts.

Authors:  M Morán; H Rivera; M Sánchez-Aragó; A Blázquez; B Merinero; C Ugalde; J Arenas; J M Cuezva; M A Martín
Journal:  Biochim Biophys Acta       Date:  2010-02-11

Review 5.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

6.  Mitochondrial genetics: a paradigm for aging and degenerative diseases?

Authors:  D C Wallace
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

7.  Intracellular pH Modulates Autophagy and Mitophagy.

Authors:  Alexey V Berezhnov; Marc P M Soutar; Evgeniya I Fedotova; Maria S Frolova; Helene Plun-Favreau; Valery P Zinchenko; Andrey Y Abramov
Journal:  J Biol Chem       Date:  2016-02-18       Impact factor: 5.157

8.  Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels.

Authors:  Masaki Kodaira; Hideyuki Hatakeyama; Shinsuke Yuasa; Tomohisa Seki; Toru Egashira; Shugo Tohyama; Yusuke Kuroda; Atsushi Tanaka; Shinichiro Okata; Hisayuki Hashimoto; Dai Kusumoto; Akira Kunitomi; Makoto Takei; Shin Kashimura; Tomoyuki Suzuki; Gakuto Yozu; Masaya Shimojima; Chikaaki Motoda; Nozomi Hayashiji; Yuki Saito; Yu-Ichi Goto; Keiichi Fukuda
Journal:  FEBS Open Bio       Date:  2015-03-20       Impact factor: 2.693

9.  Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease.

Authors:  Dar-Shong Lin; Shu-Huei Kao; Che-Sheng Ho; Yau-Huei Wei; Pi-Lien Hung; Mei-Hsin Hsu; Tsu-Yen Wu; Tuan-Jen Wang; Yuan-Ren Jian; Tsung-Han Lee; Ming-Fu Chiang
Journal:  Oncotarget       Date:  2017-09-01

10.  The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?

Authors:  Michelangelo Mancuso; Daniele Orsucci; Corrado Angelini; Enrico Bertini; Valerio Carelli; Giacomo Pietro Comi; Alice Donati; Carlo Minetti; Maurizio Moggio; Tiziana Mongini; Serenella Servidei; Paola Tonin; Antonio Toscano; Graziella Uziel; Claudio Bruno; Elena Caldarazzo Ienco; Massimiliano Filosto; Costanza Lamperti; Michela Catteruccia; Isabella Moroni; Olimpia Musumeci; Elena Pegoraro; Dario Ronchi; Filippo Maria Santorelli; Donato Sauchelli; Mauro Scarpelli; Monica Sciacco; Maria Lucia Valentino; Liliana Vercelli; Massimo Zeviani; Gabriele Siciliano
Journal:  J Neurol       Date:  2013-12-29       Impact factor: 4.849

View more
  14 in total

1.  Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.

Authors:  Sujoy Bhattacharya; Jinggang Yin; Weihong Huo; Edward Chaum
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

2.  Baicalein Attenuates Pyroptosis and Endoplasmic Reticulum Stress Following Spinal Cord Ischemia-Reperfusion Injury via Autophagy Enhancement.

Authors:  Chenyu Wu; Hui Xu; Jiafeng Li; Xinli Hu; Xingyu Wang; Yijia Huang; Yao Li; Sunren Sheng; Yongli Wang; Huazi Xu; Wenfei Ni; Kailiang Zhou
Journal:  Front Pharmacol       Date:  2020-07-30       Impact factor: 5.810

3.  Gestational long-term hypoxia induces metabolomic reprogramming and phenotypic transformations in fetal sheep pulmonary arteries.

Authors:  Eric Leslie; Vanessa Lopez; Nana A O Anti; Rafael Alvarez; Isaac Kafeero; Donald G Welsh; Monica Romero; Shawn Kaushal; Catherine M Johnson; Remy Bosviel; Ivana Blaženović; Rui Song; Alex Brito; Michael R La Frano; Lubo Zhang; John W Newman; Oliver Fiehn; Sean M Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-02-24       Impact factor: 5.464

Review 4.  The role of autophagy in cardiovascular pathology.

Authors:  Damián Gatica; Mario Chiong; Sergio Lavandero; Daniel J Klionsky
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 10.787

5.  Decreased microRNA-155 in Behcet's disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production.

Authors:  Liang Liang; Qingyun Zhou; Lujia Feng
Journal:  Arthritis Res Ther       Date:  2021-05-06       Impact factor: 5.156

6.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

Review 7.  Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.

Authors:  Weiji Lin; Pan Shen; Yaqin Song; Ying Huang; Shenghao Tu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

8.  Duodenal mucosal mitochondrial gene expression is associated with delayed gastric emptying in diabetic gastroenteropathy.

Authors:  Susrutha Puthanmadhom Narayanan; Daniel O'Brien; Mayank Sharma; Karl Miller; Peter Adams; João F Passos; Alfonso Eirin; Tamas Ordog; Adil E Bharucha
Journal:  JCI Insight       Date:  2021-01-25

9.  Betulinic acid inhibits pyroptosis in spinal cord injury by augmenting autophagy via the AMPK-mTOR-TFEB signaling pathway.

Authors:  Chenyu Wu; Huanwen Chen; Rong Zhuang; Haojie Zhang; Yongli Wang; Xinli Hu; Yu Xu; Jiafeng Li; Yao Li; Xiangyang Wang; Hui Xu; Wenfei Ni; Kailiang Zhou
Journal:  Int J Biol Sci       Date:  2021-03-11       Impact factor: 6.580

10.  Impairment of Proteasome and Autophagy Underlying the Pathogenesis of Leukodystrophy.

Authors:  Dar-Shong Lin; Che-Sheng Ho; Yu-Wen Huang; Tsu-Yen Wu; Tsung-Han Lee; Zo-Darr Huang; Tuan-Jen Wang; Shun-Jie Yang; Ming-Fu Chiang
Journal:  Cells       Date:  2020-05-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.